UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury

Molecular cancer therapeutics, 2018-03, Vol.17 (3), p.603-613

2018

Volltextzugriff (PDF)

Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death

Nature chemical biology, 2013-09, Vol.9 (9), p.548-556

2013

Volltextzugriff (PDF)

The Coup-TFII orphan nuclear receptor is an activator of the γ-globin gene

Haematologica (Roma), 2021-02, Vol.106 (2), p.474-482

2021

Volltextzugriff (PDF)

novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining

Cytometry. Part A, 2008-07, Vol.73A (7), p.626-636

2008

Volltextzugriff (PDF)

Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers

Experimental cell research, 2015-03, Vol.332 (2), p.267-277

2015

Volltextzugriff (PDF)

EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors

Pharmaceutics, 2021-04, Vol.13 (4), p.483

2021

Volltextzugriff (PDF)

Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent In vivo Activity in Mesothelioma

Clinical cancer research, 2007-10, Vol.13 (19), p.5942-5951

2007

Volltextzugriff (PDF)

The development of high-content screening (HCS) technology and its importance to drug discovery

Expert opinion on drug discovery, 2016-05, Vol.11 (5), p.501-514

2016

Volltextzugriff (PDF)

A Novel High-Content Immunofluorescence Assay as a Tool to Identify at the Single Cell Level γ-Globin Inducing Compounds

PloS one, 2015-10, Vol.10 (10), p.e0141083-e0141083

2015

Volltextzugriff (PDF)

Cell Proliferation Method: Click Chemistry Based on BrdU Coupling for Multiplex Antibody Staining

Current Protocols in Cytometry, 2015-04, Vol.72 (1), p.7.34.1-7.34.17

2015

Volltextzugriff (PDF)

Highly multiplexed phenotypic imaging for cell proliferation studies

Journal of biomolecular screening, 2014-01, Vol.19 (1), p.145-157

2014

Volltextzugriff (PDF)

An overview of cell phenotypes in HCS: limitations and advantages

Expert opinion on drug discovery, 2009-06, Vol.4 (6), p.643-657

Gasparri, Fabio

2009

Volltextzugriff (PDF)

High-content analysis of kinase activity in cells

Combinatorial chemistry & high throughput screening, 2008-08, Vol.11 (7), p.523-536

2008

Volltextzugriff (PDF)

Novel Thienoduocarmycin–Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical Studies

Molecular cancer therapeutics, 2023-12, Vol.22 (12), p.1465-1478

2023

Volltextzugriff (PDF)

Phase II study on safety and efficacy of NMS-01940153E, an MPS1 inhibitor with first-in-class potential, in adult patients with unresectable hepatocellular carcinoma (HCC) previously treated with systemic therapy

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS4185-TPS4185

2023

Volltextzugriff (PDF)

Synthesis and Biological Evaluation of RGD Peptidomimetic-Paclitaxel Conjugates Bearing Lysosomally Cleavable Linkers

Chemistry : a European journal, 2015-04, Vol.21 (18), p.6921-6929

2015

Volltextzugriff (PDF)

Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin‐Targeted Conjugate

Chemistry : a European journal, 2019-02, Vol.25 (7), p.1696-1700

2019

Volltextzugriff (PDF)

Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays

European journal of cell biology, 2009-12, Vol.88 (12), p.779-785

2009

Volltextzugriff (PDF)

Abstract 5805: A novel platform of diversified payloads to drive ADC innovation

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.5805-5805

2024

Volltextzugriff (PDF)

Monitoring of apoptosis of HL60 cells by Fourier-transform infrared spectroscopy

Biochemical journal, 2003-01, Vol.369 (Pt 2), p.239-248

2003

Volltextzugriff (PDF)

Abstract 509: The MPS1/TTK inhibitor, NMS-01940153, synergizes with tisotumab vedotin in colorectal cancer

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.509-509

2024

Volltextzugriff (PDF)

Multiparametric cell cycle analysis by automated microscopy

Journal of biomolecular screening, 2006-09, Vol.11 (6), p.586-598

2006

Volltextzugriff (PDF)

Tumor Targeting with an isoDGR–Drug Conjugate

Chemistry : a European journal, 2017-06, Vol.23 (33), p.7910-7914

2017

Volltextzugriff (PDF)

Abstract 805: NMS-P088, a FLT3-KIT-CSF-1R inhibitor with activity on FLT3 F691L as a novel agent in AML

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.805-805

2018

Volltextzugriff (PDF)

1 – 25 von 104

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(93)

Publikationsform

Sprache

Englisch
(104)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury

Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death

The Coup-TFII orphan nuclear receptor is an activator of the γ-globin gene

novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining

Mcl-1 antagonism is a potential therapeutic strategy in a subset of solid cancers

EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors

Bortezomib Inhibits Nuclear Factor-κB–Dependent Survival and Has Potent In vivo Activity in Mesothelioma

The development of high-content screening (HCS) technology and its importance to drug discovery

A Novel High-Content Immunofluorescence Assay as a Tool to Identify at the Single Cell Level γ-Globin Inducing Compounds

Cell Proliferation Method: Click Chemistry Based on BrdU Coupling for Multiplex Antibody Staining

Highly multiplexed phenotypic imaging for cell proliferation studies

An overview of cell phenotypes in HCS: limitations and advantages

High-content analysis of kinase activity in cells

Novel Thienoduocarmycin–Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical Studies

Phase II study on safety and efficacy of NMS-01940153E, an MPS1 inhibitor with first-in-class potential, in adult patients with unresectable hepatocellular carcinoma (HCC) previously treated with systemic therapy

Synthesis and Biological Evaluation of RGD Peptidomimetic-Paclitaxel Conjugates Bearing Lysosomally Cleavable Linkers

Neutrophil Elastase Promotes Linker Cleavage and Paclitaxel Release from an Integrin‐Targeted Conjugate

The TPM3-NTRK1 rearrangement is a recurring event in colorectal carcinoma and is associated with tumor sensitivity to TRKA kinase inhibition

Thymidine kinase 1 expression defines an activated G1 state of the cell cycle as revealed with site-specific antibodies and ArrayScan™ assays

Abstract 5805: A novel platform of diversified payloads to drive ADC innovation

Monitoring of apoptosis of HL60 cells by Fourier-transform infrared spectroscopy

Abstract 509: The MPS1/TTK inhibitor, NMS-01940153, synergizes with tisotumab vedotin in colorectal cancer

Multiparametric cell cycle analysis by automated microscopy

Tumor Targeting with an isoDGR–Drug Conjugate

Abstract 805: NMS-P088, a FLT3-KIT-CSF-1R inhibitor with activity on FLT3 F691L as a novel agent in AML

Suchergebnisse filtern